In line with our results and attesting to the translational relevance, reduction in C3d receptor‐mediated Stat3 signaling reduced neuroinflammation and pathology in a tau model of AD (Litvinchuk et al, 2018). The gene discussed is MAPT; the disease is Alzheimer disease.